Ritsuro Suzuki

18PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|Jun 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable.

|Jan 07, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 study.

Ayumi Fujimoto, Takeshi Maeda, Noriko Doki

|Jan 04, 2026
Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.

Fumi Nakamura, Ken Ishiyama, Ritsuro Suzuki

|Oct 29, 2025
Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.

Jason Yongsheng Chan, Ayumi Fujimoto, Gin Gin Gan

Pageof 3

Frequent Collaborators

6 joint publications

Ayumi Fujimoto

5 joint publications

Koji Izutsu

5 joint publications

Itaru Matsumura

4 joint publications

Yoshiko Atsuta